U.S. Physical Therapy, Inc.

NYSE:USPH

Medical - Care Facilities

Healthcare
$95.43 +0.19%

+$0.12 today

Market cap
$1.42B
Beta
1.16
P/E (TTM)
810.7
EPS (TTM)
$0.08
Dividend yield
2.89%
52W Low $58.19High $93.50

Volume 0.33M

Average 0.20M

USPH EBITDA Margin

EBITDA as a percentage of revenue.

U.S. Physical Therapy, Inc.NYSE: USPH

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin narrows to 9.8%

EBITDA Margin was 9.8% in Q1 FY2026, down 6.9 pp from a year earlier. On a trailing-twelve-month basis it was 14.2%, up 0.5 pp year over year. Over 3 fiscal years it widened by 0.3 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 5 analysts of 9.9% for the fiscal year ending Dec 2026, down from 14.0% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
9.8%-1.1 pp QoQ
Last fiscal yearDec 2025
14.0%+1.1 pp YoY
LTMMar 2026
14.2%+0.5 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-6.9 pp-7.4 pp-0.4 pp
1 year+1.1 pp-4.1 pp-5.2 pp
3 years+0.3 pp-4.0 pp-4.3 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
14.0%
Year-over-year change
+1.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How USPH compares with its peers on the latest reported figures

  • USPH's LTM Mar 2026 EBITDA Margin of 14.2% is the 3rd highest of the 11 companies compared; the peer median is 7.6%.
  • Its year-over-year change of +0.5 pp is the 5th highest of 11, against a peer median of -0.9 pp.
  • Over three fiscal years its change of +0.3 pp compares with a peer median of +1.8 pp.
USPH Competitors Peer median
EBITDA Margin for USPH and competitors
Company Period LTM level YoY 3-year change
GDRXGoodRx Holdings, Inc.LTM Mar 202622.0% +0.5 pp+14.6 pp
AHCOAdaptHealth Corp.LTM Apr 202616.2% -7.4 pp-5.7 pp
USPHU.S. Physical Therapy, Inc.LTM Mar 202614.2% +0.5 pp+0.3 pp
CNMDCONMED CorporationLTM Mar 202612.4% -6.5 pp+10.5 pp
NEOGNeogen CorporationLTM Aug 202611.9% +111.0 pp+3.8 pp
SEMSelect Medical Holdings CorporationLTM Mar 20269.4% +1.7 pp-0.3 pp
PNTGThe Pennant Group, Inc.LTM Mar 20265.9% -0.7 pp+2.7 pp
HCSGHealthcare Services Group, Inc.LTM Mar 20265.2% +0.9 pp+1.0 pp
ASTHAstrana Health, Inc.LTM Mar 20264.6% -1.1 pp-5.5 pp
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026-152.9% -23.0 pp—
ZBIOZenas BioPharma, Inc.FY2025-3704.3% -575.9 pp—
Peer median (excluding USPH) 7.6%-0.9 pp+1.8 pp

Competitors are the stored peer set for USPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue495.02M553.14M604.8M671.35M780.99M
Cost of Revenue377.84M441.12M483.29M547.42M623.65M
Gross Profit117.18M112.02M121.51M123.92M157.34M
Gross Margin23.7%20.3%20.1%18.5%20.1%
Research & Development00000
Selling, General & Admin46.53M46.11M058.29M0
Operating Expenses46.53M55.22M69.45M60.71M76.91M
Depreciation & Amortization11.59M14.74M15.7M18.68M22.39M
EBITDA85.73M76.09M74.37M86.91M109.66M
EBITDA Margin17.3%13.8%12.3%12.9%14.0%
Operating Income70.65M56.8M52.06M63.21M80.43M
Operating Margin14.3%10.3%8.6%9.4%10.3%
Interest Income003.77M3.94M105K
Interest Expense942K5.78M9.3M8.02M9.46M
Other Income / Expenses2.55M(1.23M)(2.69M)(3M)(2.62M)
Income Before Tax73.2M55.57M49.38M60.21M77.81M
Pre-Tax Margin14.8%10.0%8.2%9.0%10.0%
Income Tax Expense15.27M12.16M12.16M14.61M19.81M
Net Income27.82M28.27M14.67M26.46M15.06M
Net Margin5.6%5.1%2.4%3.9%1.9%
EPS (Basic)4.493.341.281.841.42
EPS (Diluted)4.493.341.281.841.42
Weighted Avg Shares12.9M12.99M14.19M15.06M15.18M
Weighted Avg Shares (Diluted)12.9M12.99M14.19M15.06M15.18M

U.S. Physical Therapy, Inc.

NYSE:USPH

Intrinsic Alpha fair value

Locked

Current Price

$95.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.